TLR4 and infection: AVR-25 has a binding potency similar to the binding of chitohexaose with TLR4 (Supplementary Fig. S2); hence, we hypothesized that, compound AVR-25 will have similar therapeutic efficacy as chitohexaose in intra-abdominal infection modeled by CLP mice, either alone, or in combination with standard of care antibiotics.